Literature DB >> 26391248

[Maintainance of a research tissue bank. (Infra)structural and quality aspects].

S Schmitt1, K Kynast2, P Schirmacher2, E Herpel3,4.   

Abstract

The availability of high quality human tissue samples and access to associated histopathological and clinical data are essential for biomedical research. Therefore, it is necessary to establish quality assured tissue biobanks that provide high quality tissue samples for research purposes. This entails quality concerns referring not only to the biomaterial specimen itself but encompassing all procedures related to biobanking, including the implementation of structural components, e.g. ethical and legal guidelines, quality management documentation as well as data and project management and information technology (IT) administration. Moreover, an integral aspect of tissue biobanks is the quality assured evaluation of every tissue specimen that is stored in a tissue biobank and used for projects to guarantee high quality assured biomaterial.

Entities:  

Keywords:  Projectmanagement; Quality control; Quality management; Research, biomedical; Technology platform

Mesh:

Year:  2015        PMID: 26391248     DOI: 10.1007/s00292-015-0083-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  23 in total

1.  The ethics of research using biobanks: reason to question the importance attributed to informed consent.

Authors:  Klaus Hoeyer; Bert-Ove Olofsson; Tom Mjörndal; Niels Lynöe
Journal:  Arch Intern Med       Date:  2005-01-10

2.  Biobanking 3.0: evidence based and customer focused biobanking.

Authors:  Daniel Simeon-Dubach; Peter Watson
Journal:  Clin Biochem       Date:  2014-01-06       Impact factor: 3.281

3.  Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.

Authors:  Jimmie Vaught; Joyce Rogers; Todd Carolin; Carolyn Compton
Journal:  J Natl Cancer Inst Monogr       Date:  2011

4.  An NCI perspective on creating sustainable biospecimen resources.

Authors:  Jimmie Vaught; Joyce Rogers; Kimberly Myers; Mark David Lim; Nicole Lockhart; Helen Moore; Sherilyn Sawyer; Jeffrey L Furman; Carolyn Compton
Journal:  J Natl Cancer Inst Monogr       Date:  2011

5.  A framework for biobank sustainability.

Authors:  Peter H Watson; Sara Y Nussbeck; Candace Carter; Sheila O'Donoghue; Stefanie Cheah; Lise A M Matzke; Rebecca O Barnes; John Bartlett; Jane Carpenter; William E Grizzle; Randal N Johnston; Anne-Marie Mes-Masson; Leigh Murphy; Katherine Sexton; Lois Shepherd; Daniel Simeon-Dubach; Nikolajs Zeps; Brent Schacter
Journal:  Biopreserv Biobank       Date:  2014-02       Impact factor: 2.300

6.  Quality Assurance in Tissue Resources Supporting Biomedical Research.

Authors:  William E Grizzle; Katherine C Sexton; Walter C Bell
Journal:  Cell Preserv Technol       Date:  2008-07-30

7.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

8.  Best practices for establishing a biobank.

Authors:  Göran Hallmans; Jimmie B Vaught
Journal:  Methods Mol Biol       Date:  2011

9.  Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization.

Authors:  Bih-Rong Wei; R Mark Simpson
Journal:  Clin Biochem       Date:  2013-12-18       Impact factor: 3.281

10.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  1 in total

Review 1.  [Merging different biobanks under one roof : Benefits and constraints on the way to a centralized biobank using the example of the BMBH].

Authors:  S Schmitt; C Döllinger; A Maier; E Herpel; P Schirmacher; R Kirsten
Journal:  Pathologe       Date:  2018-07       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.